Answers are grounded in this paper and cite their sources.
Peptides containing an α-azanorvaline residue at the C-terminus and N-[(1-methoxycarbonylalkyl)carbamoyl] group at the N-terminus have been made as inhibitors of human leucocyte elastase. A number of analogues with an amide bond replaced by a thiomethylene group have also been prepared. The analogues were tested against leucocyte elastase using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as a substrate and the results were obtained as IC50 values. Both types of analogues inhibited the leucocyte elastase; the most potent of these was N-[(1-methoxycarbonylbutyl)carbamoyl]-L-valyl-L-prolyl-α-azanorvaline phenyl ester (2)(IC50, 0.28 µM, Ki 0.02 µM).
No takes yet. Share an insight, caveat, or question.
Dutta et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: